Literature DB >> 10022405

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.

G A Kaltsas1, M G Giannulis, J D Newell-Price, J E Dacie, C Thakkar, F Afshar, J P Monson, A B Grossman, G M Besser, P J Trainer.   

Abstract

The clinical, biochemical, and radiological features of pituitary ACTH-dependent Cushing's syndrome (CS) [Cushing's disease (CD)] are often indistinguishable from those of occult ectopic ACTH-dependent CS (oEAS). We have evaluated, retrospectively, the results of simultaneous bilateral inferior petrosal sinus (IPS) ACTH sampling before and after CRH stimulation in 128 patients with ACTH-dependent CS: 107 patients with CD, 6 with oEAS, 1 with an adrenal adenoma, 1 with a pituitary gangliocytoma, and 1 with Nelson's syndrome; while, in the remaining 12, the source remains unclear. One hundred seven patients received human-sequence CRH (hCRH), and 11 received ovine CRH; another 6 patients underwent stimulation with desmopressin and hCRH, and 4 with desmopressin alone. A successful bilateral IPS catheterization and sampling (IPSCS) rate of 87.5% was obtained only after considerable experience had been gained. Sixty-nine patients with CD underwent successful bilateral IPSCS: the IPS-to-peripheral ratio of plasma ACTH value (IPS/P) rose from 9.5 +/- 1.4 to a maximum ratio of 55.8 +/- 7.5 in 67 patients, after CRH stimulation. The maximum ratio was obtained at 5 min in 60 of the 69 patients with CD; however, all 69 patients obtained a ratio of more than 2, at that time. In contrast, the 6 patients with occult ACTH-secreting neoplasms had a maximal IPS/P ratio of 1.3 +/- 0.16, and this did not change after CRH stimulation. A bilateral IPS/P ratio more than 2, obtained 5 min after CRH stimulation, had a sensitivity of 97% and a specificity of 100% in diagnosing CD. Two patients with proven active CD had an IPS/P ratio of less than 2. After successful bilateral IPSCS, the gradients between the IPS ACTH concentrations [IPS ACTH gradient (IPSG)] of more than 1.4, at 5 min after CRH stimulation, had a sensitivity of 83% in correctly lateralizing the pituitary microadenoma, compared with 72% sensitivity for magnetic resonance imaging (MRI) scanning. Furthermore, when IPSG and MRI findings were contradictory, IPSG was more often correct than MRI scanning. Although oEAS is a relatively uncommon cause of ACTH-dependent hypercortisolism (5.5% in our series), the accurate diagnosis of ACTH-dependent CS and localization of an intrapituitary microadenoma requires bilateral IPSCS with CRH stimulation, provided that the appropriate technical experience is available. hCRH is as effective a secretagogue as ovine CRH, and either may be used. The value of the combination of CRH and desmopressin stimulation requires more detailed investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022405     DOI: 10.1210/jcem.84.2.5437

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

Review 1.  Inferior petrosal sinus sampling ten years down the road.

Authors:  F Pecori Giraldi; C Invitti; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2000-05       Impact factor: 4.256

2.  Complications of inferior petrosal sinus sampling for the etiological diagnosis of Cushing's syndrome.

Authors:  J J Díez; P Iglesias
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

3.  Characterisation of ACTH related peptides in ectopic Cushing's syndrome.

Authors:  Robert L Oliver; Julian R E Davis; Anne White
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

4.  Neuroendocrine ACTH-producing tumor of the thymus--experience with 12 patients over 25 years.

Authors:  Nicola M Neary; Ariel Lopez-Chavez; Brent S Abel; Alison M Boyce; Nicholas Schaub; King Kwong; Constantine A Stratakis; Cesar A Moran; Giuseppe Giaccone; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

Review 5.  Inferior petrosal sinus sampling in Cushing's syndrome: usefulness and pitfalls.

Authors:  D A Vassiliadi; P Mourelatos; T Kratimenos; S Tsagarakis
Journal:  Endocrine       Date:  2021-06-02       Impact factor: 3.633

Review 6.  Dynamic testing in Cushing's syndrome.

Authors:  Blerina Kola; Ashley B Grossman
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

7.  Use of desmopressin as an alternative to corticotropin-releasing hormone during inferior petrosal sinus sampling in a child with Cushing's disease.

Authors:  M H Gannagé-Yared; S Slaba; T Rizk; R-M Chidiac Wehbe
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

Review 8.  Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm.

Authors:  Avital Perry; Christopher Salvatore Graffeo; Christopher Marcellino; Bruce E Pollock; Nicholas M Wetjen; Fredric B Meyer
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-24

9.  Selective use of bilateral inferior petrosal sinus sampling in patients with adrenocorticotropin-dependent Cushing's syndrome prior to transsphenoidal surgery.

Authors:  Sigrid Jehle; Jane E Walsh; Pamela U Freda; Kalmon D Post
Journal:  J Clin Endocrinol Metab       Date:  2008-09-16       Impact factor: 5.958

Review 10.  Cushing's disease.

Authors:  Martina De Martin; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.